Cerebrovascular disease is one of the leading causes of death in women
in the United States. Pregnancy and hormonal therapy have been associ
ated with an increased risk of stroke in young women. Other conditions
, more common in women, such as migraine headaches, rheumatologic diso
rders and antiphospholipid antibodies predispose women to cerebral isc
hemia. Women may also respond differently to antiplatelet therapy. The
identification and treatment of such conditions will improve outcome
in women with stroke and may prevent recurrent cerebrovascular events.